Clinical Trial Update: Prospective Evaluation of NfL as a Biomarker in ATTRv

View source ↗

Summary

This clinical trial update reports a prospective evaluation of neurofilament light chain (NfL) as a biomarker in hereditary transthyretin-mediated amyloidosis (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Transthyretin-mediated Amyloidosis

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Amyloidosis, Hereditary | Status: ACTIVE_NOT_RECRUITING